Serpil OĞUZTÜZÜN, Mesude İŞCAN, Müzeyyen ÖZHAVZALI, Serpil Dizbay SAK

Comparison of GST Isoenzyme Expression in Normal and Neoplastic Breast Tissue: Correlation with Clinical and Prognostic Factors

Glutathione S-transferases in breast tissue play an important role in the susceptibility to the mutagenic effects of chemical carcinogens and in the response of breast tumors to chemotherapy. In this study the immunohistochemical staining characteristics of glutathione S-transferase isoenzymes (alpha, mu, pi, and theta) were investigated in invasive duct carcinomas and in normal breast tissue of 43 patients. The relationships between the expression of the GST isoenzymes and some clinicopathological features were also examined. Diffuse cytoplasmic staining of varying intensity was observed for GST alpha, theta, and pi in normal and tumorous breast tissue in 100% of the samples. In normal epithelium there was a stronger intensity of staining for GST alpha, mu, and pi expression than in invasive tumor tissues (P < 0.05); however, it was statistically proven that in normal and tumor epithelial cells there was no significant difference in the GST theta isoenzyme staining scores (P > 0.05). In this study significant relationships were observed between microcalcification status and GST mu, between menopause status and GST alpha, and between tumor grade and GST mu expression (P < 0.05). The relationships between GST isoenzyme expression, and estrogen receptor status, tumor grade, smoking status, chemotherapy status, parity, patient´s age, and hormone therapy status were not statistically significant (P > 0.05).

Anahtar Kelimeler:

Glutathione-S-transferase, breast cancer, immunohistochemistry

Comparison of GST Isoenzyme Expression in Normal and Neoplastic Breast Tissue: Correlation with Clinical and Prognostic Factors

Keywords:

Glutathione-S-transferase, breast cancer, immunohistochemistry,

PDF

___

1. Harris JR, Lippman ME, Veronesi U et al. Breast Cancer. N Engl J Med 327: 319-328, 1992.
2. Kelsey JL, Berkowitz GS. Breast Cancer Epidemiology. Cancer Res. 48: 5615-5623, 1988.
3. Henderson IC. Risk factors for breast cancer development. Cancer (suppl.) 71: 2127-2140, 1993.
4. Li D, Wang M, Dhingra K et al. Aromatic DNA adducts in adjacent tissues of breast cancer patients: Clues to breast cancer etiology. Cancer Res. 56:287-293, 1996.
5. Hayes JD, Flaagan JU, Jowsey IR. Glutathione-S-Transferases. Annu Rev Pharmacol Toxicol 45: 51-88, 2005.
6. Coles BF, Kadlubar FF. Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs? Biofactors 17: 115-130, 2003.
7. Perquin M, Oster T, Maul A et al. The glutathione-related detoxification system is increased in human breast cancer in correlation with clinical and histopathological features. J Cancer Res Clin Oncol 127: 368-374, 2001.
8. Rajneesh CP, Manimaran A, Sasikala KR et al. Lipid peroxidation and antioxidant status in patients with breast cancer. Singapore Med J 49: 640-3, 2008.
9. Cairns J, Wright C, Cattan AR et al. Immunohistochemical demonstration of glutathione S-transferases in primary human breast carcinomas. J Pathol 166: 19-25, 1992.
10. Gilbert L, Elwood LJ, Merino M et al. A pilot study of pi-class glutathione S-transferase expression in breast cancer-correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J Clin Oncol 11: 49-58, 1993.
11. Wright C, Cairns J, Cantwell BJ et al. Response to mitoxantrone in advanced breast cancer: correlation with expression of c-erbB- 2 protein and glutathione S-transferases. Br J Cancer 65:271-74, 1992.
12. Sherman M, Titmuss S, Kirsch RE. Glutathione S-transferase in human organs. Biochem Int 6: 109-118, 1983. 13. Corrigall AV, Kirsch RE. Glutathione S-transferase distribution and concentration in human organs. Biochem Inter 16: 3: 443- 448, 1988.
14. Forrester LM, Hayes JD, Millis R et al. Expression of glutathione S-transferases and cytochrome P450 in normal and tumor breast tissue. Carcinogenesis 11-12: 2163-2170, 1990.
15. Shea TC, Kelley SI, Henner WD. Identification of an anionic form of GST present in many human tumors and tumor cell lines. Cancer Res. 48: 527-533, 1988.
16. Lewis AD, Forrester LM, Hayes JD et al. Glutathione enzymes in human tissues and tumor derived cell lines. Br J Cancer 60: 327- 331, 1989.
17. Shea TC, Claflin G, Comstock KE et al. Glutathione transferase activity and isoenzyme composition in primary human breast cancer. Cancer Res 50: 6848-6853, 1990.
18. Moscow JA, Townsend AJ, Goldsmith ME et al. Isolation of the human anionic GST cDNA and the relation of its gene expression to estrogen receptor content in primary breast cancer. Proc Natl Acad Sci USA 85: 6518-6522, 1988.
19. Iscan M, Coban T, Cok I et al. The organochlorine pesticide residues and antioxidant enzyme activities in human breast tumors: is there any association? Breast Cancer Research and Treatment 72: 173-182, 2002.
20. Sreenath AS, Kumar KR, Reddy GV et al. Evidence for the association of synaptotagmin with glutathione S-transferases: Implications for a novel function in human breast cancer Clinical Biochemistry 38: 436-443, 2005.
21. Mainwaring GW, Williams SM, Foster JR et al. The distribution of theta-class glutathione S-transferases in the liver and lung of mouse, rat and human. Biochem J 318: 297-303, 1996.
22. Aliya S, Reddanna P, Thyagaraju K. Does glutathione Stransferase pi a marker protein for cancer? Molecular and Cellular Biochemistry 253: 319-327, 2003.
23. Haas S, Pierl C, Harth V et al. Expression of xenobiotic and steroid hormone metabolizing enzymes in human breast carcinomas. Int J Cancer. 119: 1785-91, 2006.
24. McKay JA, Murray GI, Weaver RJ et al. Xenobiotic metabolizing enzyme expression in colonic neoplasia. Gut 34: 1234-1239, 1993.
25. Hamada S-I, Kamada M, Furumoto H et al. Expression of glutathione S-transferase-pi in human ovarian cancer as an indicator of resistance to chemotherapy. Gynecol Oncol 52: 313- 319, 1994.
26. Shiratori Y, Soma Y, Maruyama H et al. Immunohistochemical detection of the placental form of glutathione S-transferase in dysplastic and neoplastic human uterine cervix lesions. Cancer Research 47: 6806-6809, 1987.
27. Harrison DJ, Kharbanda R, Bishop D et al. Glutathione Stransferase isoenzymes in human renal carcinoma demonstrated by immunohistochemistry. Carcinogenesis 10: 1257-1260, 1989.
28. Bennet CF, Yeoman LC. Microinjected glutathione S-transferase Yb subunits translocate to the cell nucleus. Biochem J 247: 109- 112, 1987.
29. Homma H, Listowsky I. Identification of Yb-glutathione Stransferase as a major rat liver protein labeled with dexamethasone 21-methanesulfonate. Proc Natl Acad Sci USA 82: 7165-7169, 1985.
30. Peters WHM, Roelofs HMJ, van Putten WLJ et al. Response to adjuvant chemotherapy in primary breast cancer: no correlation with expression of glutathione-S-transferases. Br J Cancer 68: 86-92, 1993.
31. Silvestrini R, Veneroni S, Benini E et al. Expression of p53, glutathione-S-transferase-pi, and bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer. Journal of the National Cancer Institute 89: 9, 639-645, 1997.
32. Ambrosone CB, Sweeney C, Coles BF et al. Polymorphisms in glutathione-S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer. Cancer Research 61: 7130-7135, 2001.
33. Huang J, Tan P-H, Thiyagarajan J et al. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer. Mod Pathol 16: 558-565, 2003.
34. Chunder N, Mandal S, Basu D et al. Deletion mapping of chromosome 1 in early onset and late onset breast tumors-a comparative study in eastern India. Pathol Res Pract 199: 313- 21, 2003.
35. Listowsky I, Abramovitz M, Ishigaki S. Glutathione-S-transferases are major cytosolic thyroid hormone binding proteins. Arch Biochem Biophys 273: 265-272, 1989.
36. Kumaraguruparan R, Mohan KVPC, Nagini S. Xenobioticmetabolising enzymes in patients with adenocarcinoma of the breast: Correlation with clinical stage and menopausal status. The Breast 15: 58-63, 2006.
37. Wu SH, Tsai SM, Hou MF et al. Interaction of genetic polymorphisms in cytochrome P450 2E1 and glutathione Stransferase M1 to breast cancer in Taiwanese woman without smoking and drinking habits. Breast Cancer Res Treat 100: 93- 98, 2006.